Tricyclic Antidepressants for Chronic Low Back Pain Relief
This paper reviews the evidence for using tricyclic antidepressants — specifically Amitriptyline and Pregabalin — as treatment options for chronic low back pain (LBP). Drawing on three primary studies, the review examines the pharmacological rationale for antidepressant use in pain management, compares the relative efficacy of each drug individually, and evaluates their combined use. Findings indicate that Amitriptyline outperforms Pregabalin as a standalone treatment, while the combination of both drugs produces meaningful pain reduction but introduces adverse effects such as dizziness and constipation. The paper also addresses barriers to clinical adoption and the potential for tricyclic antidepressants to become a standard treatment alternative to NSAIDs and opioids for chronic LBP.
- Introduction and Pharmacological Background: Rationale for antidepressants in chronic low back pain
- Current Treatment Landscape for Chronic Low Back Pain: Common treatments including NSAIDs, opioids, and antidepressants
- Amitriptyline vs. Pregabalin: Head-to-Head Comparison: Randomized trial comparing individual drug efficacy
- Combined Use of Pregabalin and Amitriptyline: Combination therapy outcomes and adverse effects
- Clinical Implications and Barriers to Practice Change: Adoption challenges and nursing practice considerations
- Conclusion: Summary of findings and future research needs
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper builds a logical progression from pharmacological rationale to individual drug comparisons to combination therapy, giving the argument a clear scaffolding.
- Direct quotation of quantitative outcomes (VAS scores, ODI percentages, p-values) grounds the review in measurable evidence rather than vague claims.
- The final sections connecting research findings to real-world practice barriers demonstrate applied critical thinking beyond summarizing literature.
Key academic technique demonstrated
The paper demonstrates systematic literature synthesis: each source is introduced with its purpose, its methodology is briefly described, and its specific findings are quoted and interpreted. The author then draws cross-study comparisons to identify an overall evidence pattern, which is the core skill of a literature review.
Structure breakdown
The paper opens with background on antidepressant pharmacology and a keyword search rationale, then moves through three articles in sequence — standard treatment context, head-to-head drug comparison, and combination therapy — before addressing clinical practice implications and a conclusion. The structure mirrors a focused literature review format typical of undergraduate health sciences coursework.
Introduction and Pharmacological Background
Tricyclic antidepressant use to mitigate chronic low back pain has been investigated by researchers as a form of treatment for decades, with some articles dating as far back as 1986. The types of antidepressants tested for efficacy in treating chronic low back pain have been either tricyclic or tetracyclic. Systematic reviews from over a decade ago noted that antidepressants treat pain via inhibition of norepinephrine reuptake (Staiger, Gaster, Sullivan, & Deyo, 2003). Antidepressants that failed to inhibit norepinephrine reuptake did not provide any benefit in pain relief. Newer modalities of treatment use not just one, but a combination of agents such as Pregabalin and Amitriptyline.
Pregabalin, otherwise known as Lyrica, is a nerve pain medication. Uses for the drug include treatment of seizures, fibromyalgia, and nerve and muscle pain. Amitriptyline (Elavil) is a standard treatment for depression that also functions as a nerve pain medication. Some medical practitioners have prescribed it for insomnia as well (Atkinson & Sullivan, 2013).
These drugs have been reviewed as treatments both separately and together. Drugs that treat nerve pain are particularly relevant because chronic lower back pain consists mainly of neuropathic or nerve pain such as sciatica or lumbar radiculopathy (Jacobson et al., 2015). If drugs like Pregabalin and Amitriptyline can diminish nerve pain, they represent the most promising treatment option for chronic lower back pain. The research strategies reviewed here focus on whether Pregabalin or Amitriptyline work as primary treatment options for chronic lower back pain, or whether the two drugs work best in combination.
The search strategy uses Pregabalin and Amitriptyline as main keywords, with searches limited to current articles (less than five years old) that examine the efficacy of either or both drugs as treatment options. The additional keywords "antidepressants" and "chronic low back pain" were used to capture previous and current literature on antidepressant use for this condition.
References
Atkinson, J. H., & Sullivan, M. D. (2013). Antidepressant analgesics in pain management. Encyclopedia of Pain, 165–175. doi:10.1007/978-3-642-28753-4_247
Jacobson, E. E., Meleger, A. L., Bonato, P., Wayne, P. M., Langevin, H. M., Kaptchuk, T. J., & Davis, R. B. (2015). Structural integration as an adjunct to outpatient rehabilitation for chronic nonspecific low back pain: A randomized pilot clinical trial. Evidence-Based Complementary and Alternative Medicine, 2015, 1–19. doi:10.1155/2015/813418
Kalita, J., Kohat, A., Misra, U., & Bhoi, S. (2014). An open labeled randomized controlled trial of pregabalin versus amitriptyline in chronic low backache. Journal of the Neurological Sciences, 342(1–2), 127–132. doi:10.1016/j.jns.2014.05.002
Kanukula, R., Bansal, D., & Ghai, B. (2014). Efficacy and safety of combination of pregabalin and amitriptyline in patients with chronic low back pain in Indian population. Value in Health, 17(3), A224. doi:10.1016/j.jval.2014.03.1312
Staiger, T. O., Gaster, B., Sullivan, M. D., & Deyo, R. A. (2003). Systematic review of antidepressants in the treatment of chronic low back pain. Spine, 28(22), 2540–2545. doi:10.1097/01.brs.0000092372.73527.ba
Wong, A. Y., Karppinen, J., & Samartzis, D. (2017). Low back pain in older adults: Risk factors, management options and future directions. Scoliosis and Spinal Disorders, 12(1), 1–10. doi:10.1186/s13013-017-0121-3
Already a member? Log in
Unlock the rest of this paper
135,000+ research papers · AI writing tools · Plagiarism & AI detection
24-Hour Pass
Does not renew
Get 24-Hour PassMonthly
Renews at $12.99/month until canceled
Start MonthlyAnnual
Renews at $99/year until canceled
Start Annual- Unlimited AI writing tools
- Plagiarism and AI text detection tool
Plan details
Unlimited AI writing tools are for individual, non-automated use and are subject to our Terms of Service and abuse-prevention measures.
TextChecker scans: 1 during the 24-Hour Pass, or 5 per month with Monthly and Annual.
Prices exclude applicable tax.
Always verify citation format against your institution’s current style guide requirements.